Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 52 (RN7SKP52) is a predicted non-coding RNA gene categorized as a *pseudogene* of the functional RN7SK small nuclear RNA (snRNA) gene. Pseudogenes, by definition, are generally non-functional remnants of genes that have lost their ability to encode functional RNAs or proteins, usually due to mutations or truncations. Unlike the functional RN7SK snRNA, which plays a well-established regulatory role in controlling RNA polymerase II pausing and transcription via the 7SK snRNP complex[1][2][3], RN7SKP52 is not transcribed into a functional product, has no documented biological activity, and does not serve as a molecular drug or disease target. Therefore, it is not recognized as a therapeutically actionable site or relevant to pharmacological intervention. - The functional RN7SK snRNA is involved in cell cycle control, cellular differentiation (notably in the epidermis), and regulation of gene transcription—primarily via interactions with the P-TEFb complex and modulating RNA polymerase II activity[1][2][3]. - However, the pseudogene RN7SKP52 is a genomic artifact and does not participate in these biological pathways. - There is currently no evidence linking RN7SKP52 to disease, druggability, or clinical relevance. Note: If you intended to refer to the functional *RN7SK* gene or snRNA, which does participate in critical transcriptional regulation, please clarify. The pseudogene RN7SKP52 does not share these functional properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 52 (RN7SKP52).